Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28388008 | 0.78 | KDM4E (0.41) | KDM4EPOLBMAPK1ATMLMNA | |
| SCHEMBL3282387 | 0.72 | KDM4E (0.49) | KDM4EPOLBMAPK1ATMLMNA | |
| SCHEMBL28390322 | 0.72 | KDM4E (0.49) | KDM4EPOLBMAPK1ATMLMNA | |
| SCHEMBL13730894 | 0.72 | KDM4E (0.49) | KDM4EPOLBMAPK1ATMLMNA | |
| SCHEMBL19664183 | 0.68 | — | — | |
| SCHEMBL6274820 | 0.68 | KDM4E (0.45) | KDM4EPOLBMAPK1ATMLMNA | |
| SCHEMBL27552170 | 0.68 | KDM4E (0.49) | KDM4EPOLBMAPK1ATMLMNA | |
| SCHEMBL5921930 | 0.68 | KDM4E (0.45) | KDM4EPOLBMAPK1ATMLMNA | |
| SCHEMBL5921928 | 0.67 | KDM4E (0.44) | KDM4EPOLBMAPK1ATMLMNA | |
| SCHEMBL31464931 | 0.66 | FGFR1 (0.47) | KDM4EPOLBMAPK1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118240281-A | Graphite-phase carbon nitride-based antioxidant and preparation method and application thereof | 福州大学 | 2024-06-25 | — | — | CN | claimed |
| CN-114920790-B | Synthesis method of oligonucleotide-diimide compound | 康龙化成(宁波)科技发展有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-116218270-B | Dual-response anticorrosive filler and preparation method and application thereof | 中海油常州涂料化工研究院有限公司 | 2024-06-07 | — | — | CN | claimed |
| EP-3702354-B1 | COMPOUND HAVING ERK KINASE INHIBITORY ACTIVITY AND USE THEREOF | HAIHE BIOPHARMA CO LTD (CN) | 2024-05-22 | — | — | EP | claimed |
| CN-108148044-B | Amide compound and method for preparing Vonoprazan fumarate from same | 上海医药工业研究院 | 2024-05-14 | — | — | CN | claimed |
| CN-117820613-A | Preparation method and application of 2, 5-furandicarboxylic acid polyester synthesized by solution method | 中国科学院大连化学物理研究所 | 2024-04-05 | — | — | CN | claimed |
| CN-112851664-B | Pyrazolo [1,5-a ] pyridine-3-nitrile compound and application thereof in medicine | 浙江海正药业股份有限公司 | 2024-03-29 | — | — | CN | claimed |
| US-20240033368-A1 | PREPARATION AND PURIFICATION METHOD OF ANTIBODY DRUG CONJUGATE INTERMEDIATE | REMEGEN CO., LTD. (CN) | 2024-02-01 | — | — | US | claimed |
| CN-117448983-A | Flame-retardant and antistatic polyester fiber and preparation method thereof | 安徽大学 | 2024-01-26 | — | — | CN | claimed |
| CN-117338900-A | External gel preparation for promoting diabetic wound healing and preparation method and application thereof | 中国药科大学 | 2024-01-05 | — | — | CN | claimed |
| CN-101691399-A | Method for solid phase synthesis of bitter gourd MC-JJ6221 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ6221 peptide analogs | UNIV CHINA PHARMA | 2010-04-07 | — | — | CN | claimed |
| CN-101685274-A | Cleaning agent for thick-film photoresist | ANJI MICROELECTRONICS CO LTD | 2010-03-31 | — | — | CN | claimed |
| CN-101674835-A | Process for preparing galanthamine | SCINOPHARM TAIWAN LTD | 2010-03-17 | — | — | CN | claimed |
| CN-101665529-A | Method for promoting solid phase synthesis of balsam pear MC-JJ22 polypeptide analogue by microwaves and application thereof | UNIV CHINA PHARMA | 2010-03-10 | — | — | CN | claimed |
| CN-101665528-A | Method for promoting solid phase synthesis of balsam pear MC-JJ2 polypeptide analogue by microwaves and application thereof | UNIV CHINA PHARMA | 2010-03-10 | — | — | CN | claimed |
| CN-101613386-A | Gambogic acid cyclized analog and its production and application | LIAONING LIFENG SCIENCE AND TE | 2009-12-30 | — | — | CN | claimed |
| CN-101289482-A | Cambogic acid glycoside derivates and the like, preparation and uses thereof | LIAONING LIFENG TECHNOLOGY AND (CN) | 2008-10-22 | — | — | CN | claimed |
| CN-101274935-A | Amino acid-containing palisade porphyrin compound, preparation thereof and application thereof | INST BIOMEDICAL ENG CAMS (CN) | 2008-10-01 | — | — | CN | claimed |
| CN-101274958-A | Bioactive peptide, preparation thereof and application thereof | OCEAN UNIV CHINA (CN) | 2008-10-01 | — | — | CN | claimed |
| CN-101255191-A | Micro-wave promoted solid-phase synthesis of glucagons-like peptide-1(GLP-1) analogue and uses thereof | UNIV CHINA PHARMA (CN) | 2008-09-03 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240033368-A1 | PREPARATION AND PURIFICATION METHOD OF ANTIBODY DRUG CONJUGATE INTERMEDIATE | FCGR2A, FCGR3B, FCGR1A | KDM4E 1685/4885POLB 741/4885MAPK1 3318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.